Latest Breaking News On - Australia therapeutics goods administration - Page 1 : comparemela.com

PharmaDrug s Sairiyo Therapeutics pursuing in-human study of PD-001 in Australia following manufacturing milestone

PharmaDrug s Sairiyo Therapeutics pursuing in-human study of PD-001 in Australia following manufacturing milestone
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Robert steenAustralia therapeutics goods administrationDrug administrationPharmadrug incSairiyo therapeuticsTherapeutics goods

David says ketamine was a lifesaver for his depression So why are many in Australia missing out? | Health

A lack of commercial incentives to get the drug approved for treatment-resistant depression means people cannot afford it

Adam bayesAnthony rodgersUniversity of new south walesGeorge instituteAustralia therapeutics goods administrationJanssen pharmaceuticalsDog instituteNew zealand journalTherapeutics goods administrationPharmaceutical benefits schemeProf anthony rodgersNew south walesProf colleen looBlack dog institute

Veru, Inc (VERU) Granted Expedited Provisional Registration Regulatory Pathway for Sabizabulin in Australia

Veru, Inc (VERU) Granted Expedited Provisional Registration Regulatory Pathway for Sabizabulin in Australia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesMitchell steinerSamuel fischexecutiveEli lillyVeru incData monitoring committeeEuropean medicines agency emergency taskExchange commissionCompany formCompany onAustralia is adjutor healthcare pty ltdAustralia therapeutic goods administrationEuropean unionAustralia therapeutics goods administrationHealthcare products regulatory agency

Invex Therapeutics approved to start Presendin phase three clinical trial in Australia

Clinical-stage biopharmaceutical company Invex Therapeutics (ASX: IXC) has been given the green light to start its EVOLVE phase three clinical trial in Australia on patients with idiopathic intracranial hypertension (IIH).

United kingdomAlex sinclairAustralia human research ethics committeeHuman research ethics committeeTherapeutics goods administrationAustralia therapeutics goods administrationInvex therapeuticsTrial notificationClinical trial notificationProfessor alex sinclair

Australia s Lifespot Health Rebrands, Changes Ticker

The company previously known as Lifespot Health Ltd (ASX:LSH) has completed the process of changing its name to InhaleRx Limited (ASX:IRX).

United statesUnited kingdomLifespot inhalerxInhalerx limitedLifespot health ltdUniversity of londonDrug administrationAustralia therapeutics goods administrationMedihale inhalerTherapeutics goods administrationMatthew goldenAndrew saich